“…A newly discovered EBNA1 subvariant, P-thr-sv-5, could be a potential diagnostic marker, as it represented a UCNT-specific EBNA1 subvariant. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Furthermore, COMPARE analysis indicated that the activity of NSC757963 is similar to the antituberculosis agent rifamycin SV, this was confirmed by testing the antimycobacterial activity of NSC757963 against Mycobacterium tuberculosis, results revealed potent activity suitable for use in clinical practice. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…To overcome the limit of the SV detection, the DXWR transcriptome was also sequenced and compared with the Nipponbare transcriptome to discover the genes which could have been lost in DXWR during domestication. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…To elucidate the clinical significance of the protein expression of the signature genes overexpressed in CD5(+) DLBCL with regard to all DLBCL, not otherwise specified (NOS), 10 genes (SH3BP5,LMO3,SNAP25,SYT5,SV2C,CABP1,FGF1,FGFR2,NEUROD1, and SYN2) were selected and examined immunohistochemically with samples from 28 patients with DLBCL, NOS. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…CONCLUSION: Effective doses received by the patient from (68)Ge in the injected radiopharmaceutical (68)Ga-DOTATATE are lower than 0.1 μSv and are therefore practically negligible, especially when compared with the contribution of the PET radiopharmaceutical itself. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…The Tampa Scale of Kinesiophobia Swedish Version for the Heart (TSK-SV Heart) is reliable and has been validated for cardiac diseases in the Swedish population. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…An analysis of the cost and radiation exposure showed savings of 7000 Є and 100 mSv, respectively. CONCLUSIONS: No unrecognized diagnostic with a clinical impact due to the lack of CXR and PXR during the initial management of stable trauma patients was observed. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…In the 1990s, we used the SV40 large T antigen to immortalize dopaminergic neurons derived from Embryonic Day 14 rat mesencephalon. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Rats with carbon tetrachloride-induced liver cirrhosis were treated with controls or with adeno-associated virus 1 (AAV) or simian virus 40 (SV40) vectors expressing IGF-I (AAVIGF-I or SVIGF-I) and molecular and histological studies were performed at 4 days, 8 weeks and 16 weeks. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…In hypothermia group, PO(2), SvO(2) and lactate were improved significantly compared to pre-cooling (P <0.05), and they were significantly better than the northermia group at the 36(th) hour (P <0.05%). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…RESULTS: While the effective dose was lower with 192-slice DSCT (1.2 ± 0.5 vs. 0.6 ± 0.3 mSv; P < 0.001), the SNR (18.9 ± 4.3 vs. 11.0 ± 2.9; P < 0.001) and CNR (23.5 ± 4.8 vs. 14.3 ± 4.1; P < 0.001) were superior to 128-slice DSCT. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…The estimated radiation doses for lower extremity and coronary CTA were 3.6 ± 1.2 and 5.5 ± 4.5 mSv. A significant coronary stenosis was detected in 47 patients (45.6%). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Although the effective dose, 0.0298 mSv/MBq, is slightly greater than for other common (18)F PET imaging radiopharmaceuticals, the biodistribution and radiation dosimetry profile remain favourable for clinical PET imaging.…”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…ADNI model trained on AD vs. Controls using SV could predict MCI-DEM patients with 67% accuracy. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…In dorsal hippocampus (DHIPP) and ventral hippocampus (VHIPP), lithium-responsive C57BL/6J and 129S6/SvEvTac mice show decreased PDE11A4 protein expression relative to lithium-unresponsive BALB/cJ mice. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…In a luciferase reporter construct, replacement of the SV40 poly(A) fragment by the 3UTR of Ppar?2 mRNA reduced the expression of luciferase transcripts in ZFP36L1-overexpressing cells. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Radiation dose was significantly lower in the 100 kV group (10.7 ± 4.1 vs. 20.7 ± 10.7 mSv; p < 0.001). CONCLUSIONS: 100 kV TRO-CTA is feasible in normal-to-overweight patients while maintaining image quality and achieving substantial dose reduction. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…There was a small increase in the median cumulative ERD with MPI (9.6 vs. 8.8 mSv, P = 0.04), but no difference in costs between the two strategies at 12 months. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…At IC(50) for HAase activity inhibition (5-20 μg/ml [0.4-1.7 μM]), sHA-F significantly inhibited proliferation, motility and invasion of HYAL-1 expressing BCa cells (253J-Lung, HT1376, UMUC-3), P<0.001. sHA-F did not affect the growth of HYAL-1 non-expressing BCa (5637, RT4, T24, TCCSUP) and normal urothelial (Urotsa, SV-HUC1) cells. sHA-F treatment induced apoptosis by death receptor pathway. sHA-F downregulated transcript and/or protein levels of HA receptors (CD44, RHAMM), p-AKT, β-catenin, pβ-Catenin(S552), Snail and Twist but increased levels of pβ-Catenin(T41/S45), pGSK-3α/β(S21/S9) and E-cadherin. sHA-F also inhibited CD44/Phosphoinositide 3-kinase (PI-3K) complex formation and PI-3K activity. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Dosimetry calculations predict that 370 MBq of (51)Mn in an adult human male would yield an effective dose equivalent of approximately 13.5 mSv, roughly equivalent to a clinical [(18)F]-FDG procedure.…”
Enlace del recurso
Enlace del recurso
Enlace del recurso